PMID: 6108726Jul 1, 1980Paper

Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm

Allergy
B HegardtN Svedmyr

Abstract

The selective anti-allergic effect of a new beta-agonist, KWD 2131, in inhibiting allergen-provoked asthma was compared with that of placebo in a double-blind crossover study. Non-bronchodilating doses were given by inhalation to 12 asymptomatic patients with extrinsic asthma. KWD 2131 showed a marginal anti-allergic effect. A significantly better effect than that with placebo was obtained at only one time of measurement after challenge (P < 0.05). The reproducibility of the allergen challenge was also evaluated. The mean maximum decrease in FEV1 during three different allergen-challenge procedures was 37, 31, and 38%, respectively. The difference was not statistically significant.

References

Jul 1, 1978·Clinical Allergy·D W CockcroftF E Hargreave
Oct 1, 1975·The Journal of Allergy and Clinical Immunology·H ChaiR G Townley
Nov 1, 1975·The Journal of Allergy and Clinical Immunology·R R RosenthalW R Summer
Jan 1, 1971·International Archives of Allergy and Applied Immunology·E S Assem, H O Schild
Jan 1, 1971·International Archives of Allergy and Applied Immunology·R P Orange, K F Austen
Aug 30, 1968·Science·L M Lichtenstein, S Margolis
Dec 8, 1973·British Medical Journal·D H BryantL Lazarus
Feb 1, 1969·Pediatric Clinics of North America·E A Bronsky, E F Ellis
Jun 1, 1980·Allergy·O Loẅhagen, N B Lindholm

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.